• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒感染与治疗的表观遗传学意义。

The epigenetic implication in coronavirus infection and therapy.

机构信息

Laboratorio di Epigenetica, Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, 27100, Pavia, Italy.

Laboratorio di Cardiologia Molecolare, Policlinico San Donato IRCCS, Milan, Italy.

出版信息

Clin Epigenetics. 2020 Oct 21;12(1):156. doi: 10.1186/s13148-020-00946-x.

DOI:10.1186/s13148-020-00946-x
PMID:33087172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7576975/
Abstract

Epigenetics is a relatively new field of science that studies the genetic and non-genetic aspects related to heritable phenotypic changes, frequently caused by environmental and metabolic factors. In the host, the epigenetic machinery can regulate gene expression through a series of reversible epigenetic modifications, such as histone methylation and acetylation, DNA/RNA methylation, chromatin remodeling, and non-coding RNAs. The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China, and spread worldwide, causes it. COVID-19 severity and consequences largely depend on patient age and health status. In this review, we will summarize and comparatively analyze how viruses regulate the host epigenome. Mainly, we will be focusing on highly pathogenic respiratory RNA virus infections such as coronaviruses. In this context, epigenetic alterations might play an essential role in the onset of coronavirus disease complications. Although many therapeutic approaches are under study, more research is urgently needed to identify effective vaccine or safer chemotherapeutic drugs, including epigenetic drugs, to cope with this viral outbreak and to develop pre- and post-exposure prophylaxis against COVID-19.

摘要

表观遗传学是一门相对较新的科学领域,研究与遗传和非遗传相关的表型变化,这些变化通常由环境和代谢因素引起。在宿主中,表观遗传机制可以通过一系列可逆的表观遗传修饰来调节基因表达,如组蛋白甲基化和乙酰化、DNA/RNA 甲基化、染色质重塑和非编码 RNA。2019 年冠状病毒病(COVID-19)是一种高度传染性和致病性的病毒感染。它由在中国武汉出现并在全球传播的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起。COVID-19 的严重程度和后果在很大程度上取决于患者的年龄和健康状况。在这篇综述中,我们将总结和比较分析病毒如何调节宿主的表观基因组。主要关注的是高致病性呼吸道 RNA 病毒感染,如冠状病毒。在这种情况下,表观遗传改变可能在冠状病毒病并发症的发生中发挥重要作用。虽然正在研究许多治疗方法,但迫切需要更多的研究来确定有效的疫苗或更安全的化疗药物,包括表观遗传药物,以应对这一病毒爆发,并开发针对 COVID-19 的暴露前和暴露后预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e665/7579918/2de1b5b7af46/13148_2020_946_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e665/7579918/5d8b32a1c208/13148_2020_946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e665/7579918/2de1b5b7af46/13148_2020_946_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e665/7579918/5d8b32a1c208/13148_2020_946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e665/7579918/2de1b5b7af46/13148_2020_946_Fig2_HTML.jpg

相似文献

1
The epigenetic implication in coronavirus infection and therapy.冠状病毒感染与治疗的表观遗传学意义。
Clin Epigenetics. 2020 Oct 21;12(1):156. doi: 10.1186/s13148-020-00946-x.
2
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.
3
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review.严重呼吸道病毒感染的表观遗传易感性及其治疗意义:叙事性综述。
Br J Anaesth. 2020 Dec;125(6):1002-1017. doi: 10.1016/j.bja.2020.06.060. Epub 2020 Aug 20.
4
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.表观遗传调控 ACE2 和干扰素调节基因可能提示狼疮患者 COVID-19 的易感性和严重程度增加。
Clin Immunol. 2020 Jun;215:108410. doi: 10.1016/j.clim.2020.108410. Epub 2020 Apr 8.
5
Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.通过对固有免疫的控制调节来预防和治疗 COVID-19 疾病。
Eur J Immunol. 2020 Jul;50(7):932-938. doi: 10.1002/eji.202048693. Epub 2020 Jun 15.
6
Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.表观遗传学在新冠病毒感染过程中影响宿主免疫中的作用。
Biochim Biophys Acta Mol Basis Dis. 2023 Mar;1869(3):166634. doi: 10.1016/j.bbadis.2022.166634. Epub 2022 Dec 26.
7
Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.冠状病毒感染对宿主表观基因组的调控及 COVID-19 超越遗传学的治疗模式。
Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5947-5964. doi: 10.26355/eurrev_202110_26872.
8
Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents.靶向 SARS-CoV-2 受体作为降低感染性和改善抗病毒及免疫反应的手段:一种克服抗病毒药物耐药性的基于算法的方法。
Emerg Microbes Infect. 2020 Dec;9(1):1397-1406. doi: 10.1080/22221751.2020.1776161.
9
Drug Discovery Strategies for SARS-CoV-2.针对 SARS-CoV-2 的药物研发策略。
J Pharmacol Exp Ther. 2020 Oct;375(1):127-138. doi: 10.1124/jpet.120.000123. Epub 2020 Jul 28.
10
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.探讨 2019 年冠状病毒病:具有抗 SARS-CoV-2 潜在活性的已上市药物的作用机制。
Biochem Pharmacol. 2020 Oct;180:114169. doi: 10.1016/j.bcp.2020.114169. Epub 2020 Jul 23.

引用本文的文献

1
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.《COVID-19组学报告:从个体组学方法到精准医学》
Reports (MDPI). 2023 Sep 22;6(4):45. doi: 10.3390/reports6040045.
2
Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections.利用表观遗传学:诊断和对抗病毒性急性呼吸道感染的创新方法。
Pathogens. 2025 Feb 1;14(2):129. doi: 10.3390/pathogens14020129.
3
Exploring in Ischemic Stroke and Moyamoya Disease: From Cellular Models to Clinical Insights.缺血性中风和烟雾病的探索:从细胞模型到临床见解

本文引用的文献

1
Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19.年轻患者和老年患者的 COVID-19 疾病比较:COVID-19 的隐匿性病毒脱落。
J Infect Chemother. 2021 Jan;27(1):70-75. doi: 10.1016/j.jiac.2020.09.003. Epub 2020 Sep 6.
2
Implications of COVID-19 for an ageing population.2019冠状病毒病对老年人口的影响。
Med J Aust. 2020 Oct;213(8):342-344.e1. doi: 10.5694/mja2.50785. Epub 2020 Sep 18.
3
Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.
Biomedicines. 2024 Dec 26;13(1):17. doi: 10.3390/biomedicines13010017.
4
A central role of stimulator of interferon genes' adaptor protein in defensive immune response.干扰素基因衔接蛋白刺激物在防御性免疫反应中的核心作用。
Immunol Res. 2025 Jan 21;73(1):39. doi: 10.1007/s12026-024-09587-1.
5
Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome.衰老中的表观遗传机制:外在因素与肠道微生物群
Genes (Basel). 2024 Dec 14;15(12):1599. doi: 10.3390/genes15121599.
6
The COVID-19 legacy: consequences for the human DNA methylome and therapeutic perspectives.新冠疫情的遗留影响:对人类DNA甲基化组的后果及治疗前景。
Geroscience. 2025 Feb;47(1):483-501. doi: 10.1007/s11357-024-01406-7. Epub 2024 Nov 5.
7
Virus-Induced Histone Lactylation Promotes Virus Infection in Crustacean.病毒诱导的组蛋白乳酰化促进甲壳动物的病毒感染。
Adv Sci (Weinh). 2024 Aug;11(30):e2401017. doi: 10.1002/advs.202401017. Epub 2024 Jun 14.
8
Sperm epigenetics and male infertility: unraveling the molecular puzzle.精子表观遗传学与男性不育:揭开分子谜题。
Hum Genomics. 2024 Jun 4;18(1):57. doi: 10.1186/s40246-024-00626-4.
9
Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions.长新冠或新冠后状况:过去、现在和未来的研究方向。
Microorganisms. 2023 Dec 11;11(12):2959. doi: 10.3390/microorganisms11122959.
10
Virus hijacking of host epigenetic machinery to impair immune response.病毒劫持宿主表观遗传机制以损害免疫反应。
J Virol. 2023 Sep 28;97(9):e0065823. doi: 10.1128/jvi.00658-23. Epub 2023 Sep 1.
非编码RNA的潜在用途及靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)5'非翻译区的创新治疗策略
Epigenomics. 2020 Aug;12(15):1349-1361. doi: 10.2217/epi-2020-0162. Epub 2020 Sep 2.
4
Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects.维生素 D 在预防和治疗 COVID-19 中的作用:当前的观点和未来的前景。
J Am Coll Nutr. 2021 Sep-Oct;40(7):632-645. doi: 10.1080/07315724.2020.1806758. Epub 2020 Sep 1.
5
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19.吸入式GapmeR与重组血管紧张素转换酶2联合治疗新型冠状病毒肺炎
Front Mol Biosci. 2020 Aug 7;7:197. doi: 10.3389/fmolb.2020.00197. eCollection 2020.
6
Natural products as LSD1 inhibitors for cancer therapy.用于癌症治疗的天然产物作为赖氨酸特异性去甲基化酶1(LSD1)抑制剂
Acta Pharm Sin B. 2020 Jun 20;11(3):621-31. doi: 10.1016/j.apsb.2020.06.007.
7
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.羟氯喹治疗 SARS-CoV-2 期间的分子作用和视网膜病变:CYP450 同工酶和表观遗传调控的作用。
Eur J Pharmacol. 2020 Nov 5;886:173454. doi: 10.1016/j.ejphar.2020.173454. Epub 2020 Aug 4.
8
Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?β-葡聚糖诱导的训练免疫能否成为预防 COVID-19 的手段?
Front Immunol. 2020 Jul 14;11:1782. doi: 10.3389/fimmu.2020.01782. eCollection 2020.
9
Management of epigenomic networks entailed in coronavirus infections and COVID-19.冠状病毒感染和 COVID-19 中涉及的表观基因组网络的管理。
Clin Epigenetics. 2020 Aug 5;12(1):118. doi: 10.1186/s13148-020-00912-7.
10
SARS-CoV-2 and cancer: Are they really partners in crime?SARS-CoV-2 与癌症:它们真的是同谋吗?
Cancer Treat Rev. 2020 Sep;89:102068. doi: 10.1016/j.ctrv.2020.102068. Epub 2020 Jul 11.